317 related articles for article (PubMed ID: 29884228)
1. Elevated levels of plasma symmetric dimethylarginine and increased arginase activity as potential indicators of cardiovascular comorbidity in rheumatoid arthritis.
Chandrasekharan UM; Wang Z; Wu Y; Wilson Tang WH; Hazen SL; Wang S; Elaine Husni M
Arthritis Res Ther; 2018 Jun; 20(1):123. PubMed ID: 29884228
[TBL] [Abstract][Full Text] [Related]
2. Asymmetric and symmetric dimethylarginine concentration as an indicator of cardiovascular diseases in rheumatoid arthritis patients: a systematic review and meta-analysis of case-control studies.
Zafari P; Zarifian A; Alizadeh-Navaei R; Taghadosi M; Rafiei A; Samimi Z; Niksolat F
Clin Rheumatol; 2020 Jan; 39(1):127-134. PubMed ID: 31376089
[TBL] [Abstract][Full Text] [Related]
3. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive arginine metabolomics and peripheral vasodilatory capacity in rheumatoid arthritis: A monocentric cross-sectional study.
Erre GL; Mangoni AA; Passiu G; Bassu S; Castagna F; Carru C; Piga M; Zinellu A; Sotgia S
Microvasc Res; 2020 Sep; 131():104038. PubMed ID: 32622695
[TBL] [Abstract][Full Text] [Related]
5. Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammation.
Kwaśny-Krochin B; Głuszko P; Undas A
Pol Arch Med Wewn; 2012; 122(6):270-6. PubMed ID: 22549098
[TBL] [Abstract][Full Text] [Related]
6. Nitric Oxide-Related Biological Pathways in Patients with Major Depression.
Baranyi A; Amouzadeh-Ghadikolai O; Rothenhäusler HB; Theokas S; Robier C; Baranyi M; Koppitz M; Reicht G; Hlade P; Meinitzer A
PLoS One; 2015; 10(11):e0143397. PubMed ID: 26581044
[TBL] [Abstract][Full Text] [Related]
7. Symmetrical (SDMA) and asymmetrical dimethylarginine (ADMA) in sepsis: high plasma levels as combined risk markers for sepsis survival.
Winkler MS; Nierhaus A; Rösler G; Lezius S; Harlandt O; Schwedhelm E; Böger RH; Kluge S
Crit Care; 2018 Sep; 22(1):216. PubMed ID: 30231905
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes.
Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA
Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528
[TBL] [Abstract][Full Text] [Related]
9. Metabolites of the Nitric Oxide (NO) Pathway Are Altered and Indicative of Reduced NO and Arginine Bioavailability in Patients with Cardiometabolic Diseases Complicated with Chronic Wounds of Lower Extremities: Targeted Metabolomics Approach (LC-MS/MS).
Krzystek-Korpacka M; Wiśniewski J; Fleszar MG; Bednarz-Misa I; Bronowicka-Szydełko A; Gacka M; Masłowski L; Kędzior K; Witkiewicz W; Gamian A
Oxid Med Cell Longev; 2019; 2019():5965721. PubMed ID: 31396302
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric dimethylarginine levels in thyroid diseases.
Arikan E; Karadag CH; Guldiken S
J Endocrinol Invest; 2007 Mar; 30(3):186-91. PubMed ID: 17505150
[TBL] [Abstract][Full Text] [Related]
11. Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration.
Surdacki A; Martens-Lobenhoffer J; Wloch A; Gluszko P; Rakowski T; Dubiel JS; Bode-Böger SM
Metabolism; 2009 Mar; 58(3):316-8. PubMed ID: 19217445
[TBL] [Abstract][Full Text] [Related]
12. Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation.
Dimitroulas T; Hodson J; Sandoo A; Smith J; Kitas GD
Arthritis Res Ther; 2017 Feb; 19(1):32. PubMed ID: 28183353
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Lung; 2017 Dec; 195(6):717-727. PubMed ID: 28852826
[TBL] [Abstract][Full Text] [Related]
14. Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.
Vögeli A; Ottiger M; Meier MA; Steuer C; Bernasconi L; Kulkarni P; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Respir Res; 2017 Jan; 18(1):25. PubMed ID: 28114935
[TBL] [Abstract][Full Text] [Related]
15. L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies.
Tamás P; Bódis J; Sulyok E; Kovács GL; Hantosi E; Molnár G; Martens-Lobenhoffer J; Bode-Böger SM
Scand J Clin Lab Invest; 2013 Aug; 73(5):436-43. PubMed ID: 23777299
[TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
Davids M; Teerlink T
Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
[TBL] [Abstract][Full Text] [Related]
17. Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.
Weinberg JB; Yeo TW; Mukemba JP; Florence SM; Volkheimer AD; Wang H; Chen Y; Rubach M; Granger DL; Mwaikambo ED; Anstey NM
J Infect Dis; 2014 Sep; 210(6):913-22. PubMed ID: 24620026
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats.
Szlęzak D; Ufnal M; Drapała A; Samborowska E; Wróbel M
Amino Acids; 2023 Apr; 55(4):529-539. PubMed ID: 36802034
[TBL] [Abstract][Full Text] [Related]
19. Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk.
Tang WH; Wang Z; Cho L; Brennan DM; Hazen SL
J Am Coll Cardiol; 2009 Jun; 53(22):2061-7. PubMed ID: 19477356
[TBL] [Abstract][Full Text] [Related]
20. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
